Insight journal, Insight journal - Company

M&A Activity for Acorda Therapeutics

Posted on 31 May 2014

Tags: , , ,

Acorda Therapeutics has announced only 1 M&A deal since 2009.         

In December 2012, Acorda Therapeutics announced the acquisition of Neuronex, a company developing nasal spray formulation of diazepam. The nasal spray is an addition to Acorda’s pipeline and bolsters its core strategy to develop and commercialize products to enhance neurological disorder treatments

Acorda paid $26 million for the purchase that included upfront, milestone and research funding payments.

View the full details of the deals at Current Agreements (subscription required)

Our report provides more detailed insight into the details of the deal. See: Partnering Agreements with Acorda Therapeutics 2009-2014


Summary profile data for Acorda Therapeutics

Partnering interests for Acorda Therapeutics

Partnering activity for Acorda Therapeutics                                


Related reports from Current Partnering

Report: Partnering Deals and Alliances with Acorda Therapeutics


Available resources for deal coverage for Acorda Therapeutics

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Acorda Therapeutics company profile, recent partnering, M&A and financing news and articles



Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply